SEARCH :
Featured Health Topics
Allergy
Alzheimer's Disease
Arthritis
Asthma
Breast Cancer
Cholesterol
Cold and Flu
Colon Cancer
Diabetes
Dieting
Epilepsy
Hair Loss
Headache
Heartburn
HIV & AIDS
Kidney Health
Leukemia
Lung Cancer
Lymphoma
Men's Health
Mental Health
Multiple Sclerosis
Nutrition
Osteoporosis
Parkinson's Disease
Prostate Health
Skin Health
Sleep Disorders
Women's Health
View All Health Topics
Search :
Find a therapist near you
City or Zip Code:
Powered by: Psychology Today
Advertisement
Cancer
Living with Cancer
The number of cells containing the genetic defect in some leukemias can be reduced
Today, highly sensitive tests can identify the presence of the gene responsible for chronic myeloid leukemia (CML). Just one cancerous cell can be detected among hundreds of thousands of cells. The faulty gene, found on the Philadelphia chromosome, creates an enzyme that interferes with the regulation of white blood cell production. The result is an explosion in the growth of white blood cells, the hallmark of CML. A novel medication tackles the disease by reducing the number of white blood cells and the number of cells containing the faulty gene.
RELATED PROGRAMS
Video
-
The Faulty Gene Behind Chronic Myeloid Leukemia
Transcript
Video
-
Monitoring Therapy in Chronic Myeloid Leukemia
Transcript
Article
-
Making Tough Treatment Decisions About Leukemia
Advertisement
What's this?
We subscribe to the HONcode principles.
Verify here
Disclaimer
|
Privacy Policy
|
Term of Service
|
Contact Us
|
Your Total Health
| Copyright ©2008 Healthology, Inc.